[{"address1": "2-5-1, Nihonbashi-Honcho", "address2": "Chuo-Ku", "city": "Tokyo", "zip": "103-8411", "country": "Japan", "phone": "81 3 3244 3000", "website": "https://www.astellas.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.", "fullTimeEmployees": 14754, "companyOfficers": [{"maxAge": 1, "name": "Mr. Naoki  Okamura BSc", "age": 61, "title": "President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1958208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Atsushi  Kitamura", "title": "Senior Executive Officer & CFO", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nobue  Yasuda", "title": "General Manager of Finance & Accounting Department", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yoshitsugu  Shitaka Ph.D.", "title": "Chief Scientific Officer & Senior Managing Executive Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine B. Levitt", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Katsuyoshi  Sugita", "age": 56, "title": "Chief People Officer, Chief Ethics & Compliance Officer, EVP of HR and Representative Director", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stig  Ogata", "title": "Vice President of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tatjana  Dragovic", "title": "Senior VP and Head of Ethics & Compliance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nobuaki  Tanaka", "title": "President of Japan Commercial & Senior Corporate Executive", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jun  Kono", "title": "Senior Executive Officer & Head of Japan Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 1, "boardRisk": 2, "compensationRisk": 1, "shareHolderRightsRisk": 6, "overallRisk": 2, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.astellas.com/en/ir/", "maxAge": 86400, "priceHint": 2, "previousClose": 11.0, "open": 11.0, "dayLow": 11.0, "dayHigh": 11.1, "regularMarketPreviousClose": 11.0, "regularMarketOpen": 11.0, "regularMarketDayLow": 11.0, "regularMarketDayHigh": 11.1, "dividendRate": 0.48, "dividendYield": 0.039, "exDividendDate": 1727654400, "payoutRatio": 5.8382, "fiveYearAvgDividendYield": 2.72, "beta": 0.294, "trailingPE": 152.625, "forwardPE": 26.543478, "volume": 4355, "regularMarketVolume": 4355, "averageVolume": 2540, "averageVolume10days": 410, "averageDailyVolume10Day": 410, "bid": 11.4, "ask": 12.9, "bidSize": 36200, "askSize": 40700, "marketCap": 22143567872, "fiftyTwoWeekLow": 9.13, "fiftyTwoWeekHigh": 15.27, "priceToSalesTrailing12Months": 0.013011806, "fiftyDayAverage": 10.6402, "twoHundredDayAverage": 10.80515, "trailingAnnualDividendRate": 70.0, "trailingAnnualDividendYield": 6.3636365, "currency": "USD", "enterpriseValue": 711592443904, "profitMargins": 0.01264, "floatShares": 1728681534, "sharesOutstanding": 1789859968, "heldPercentInsiders": 0.00247, "heldPercentInstitutions": 0.50967, "impliedSharesOutstanding": 1813560064, "bookValue": 936.236, "priceToBook": 0.013041583, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 0.135, "netIncomeToCommon": 21518999552, "trailingEps": 0.08, "forwardEps": 0.46, "pegRatio": 69169.2, "lastSplitFactor": "5:1", "lastSplitDate": 1395878400, "enterpriseToRevenue": 0.418, "enterpriseToEbitda": 2.542, "52WeekChange": -0.2003929, "SandP52WeekChange": 0.24014747, "lastDividendValue": 0.231, "lastDividendDate": 1711584000, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "ALPMF", "underlyingSymbol": "ALPMF", "shortName": "Astellas Pharma, Inc.", "longName": "Astellas Pharma Inc.", "firstTradeDateEpochUtc": 1272288600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f67bcc46-0813-38e0-9323-7bf0cf674275", "messageBoardId": "finmb_874641", "gmtOffSetMilliseconds": -14400000, "currentPrice": 12.21, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 302928003072, "totalCashPerShare": 169.175, "ebitda": 279988994048, "totalDebt": 992657014784, "quickRatio": 0.657, "currentRatio": 0.903, "totalRevenue": 1701805948928, "debtToEquity": 59.212, "revenuePerShare": 949.525, "returnOnAssets": 0.0182, "returnOnEquity": 0.01322, "freeCashflow": 115574628352, "operatingCashflow": 172877004800, "earningsGrowth": 0.137, "revenueGrowth": 0.262, "grossMargins": 0.81509, "ebitdaMargins": 0.16452, "operatingMargins": 0.11270001, "financialCurrency": "JPY", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]